LQFLX
Price
$15.21
Change
+$0.04 (+0.26%)
Updated
Oct 6 closing price
Net Assets
68.16M
RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

LQFLX vs RMFCX

Header iconLQFLX vs RMFCX Comparison
Open Charts LQFLX vs RMFCXBanner chart's image
Lord Abbett Focused Large Cap Value R3
Price$15.21
Change+$0.04 (+0.26%)
VolumeN/A
Net Assets68.16M
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
LQFLX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
LQFLX vs. RMFCX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQFLX is a Buy and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. LQFLX (68.2M). RMFCX pays higher dividends than LQFLX: RMFCX (1.20) vs LQFLX (0.31). LQFLX was incepted earlier than RMFCX: LQFLX (6 years) vs RMFCX (23 years). LQFLX (1.89) is less costly to investors than RMFCX (0.91). LQFLX is a more actively managed with annual turnover of: 58.00 vs. RMFCX (31.00). LQFLX has a lower initial minimum investment than RMFCX: LQFLX (0) vs RMFCX (250). LQFLX annual gain was more profitable for investors over the last year : 14.96 vs. RMFCX (7.44). RMFCX return over 5 years is better than : 60.80 vs. LQFLX (13.21).
LQFLXRMFCXLQFLX / RMFCX
Total Expense Ratio1.210.91133%
Annual Report Gross Expense Ratio1.890.91208%
Fund Existence6 years23 years-
Gain YTD16.15614.964108%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets68.2M112B0%
Annual Yield % from dividends0.311.2025%
Returns for 1 year14.967.44201%
Returns for 3 years20.7043.8447%
Returns for 5 years13.2160.8022%
Returns for 10 yearsN/A94.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.